Kankakee,
08
March
2017
|
04:22 PM
America/Chicago

Riverside Medical Center Earns National Accreditation from the Commission on Cancer

Mehmet Sipahi, MD
"This recognition attests to Riverside's commitment to providing the best cancer care possible to the communities we serve," said Dr. Mehmet Sipahi, medical oncologist, hematologist and Medical Director of the Rush-Riverside Cancer Institute. "Our staff is dedicated to the continual improvement of quality of care and ease of access. This accreditation further exemplifies that the care received at Riverside is among the best in the region."
Mehmet Sipahi, MD

Rush-Riverside Cancer Institute recognized for multidisciplinary approach to cancer care.

KANKAKEE, IL (March 8, 2017) - Riverside Medical Center and the Rush-Riverside Cancer Institute have been granted a three-year accreditation by the Commission on Cancer (CoC), a cancer care quality program of the American College of Surgeons (ACS).

In order to earn voluntary CoC accreditation, a cancer program must:

  • Meet 34 CoC quality care standards
  • Be evaluated every three years through a survey process
  • Maintain levels of excellence in the delivery of comprehensive, patient-centered care

As a CoC accredited cancer program, the Rush-Riverside Cancer Institute takes a multidisciplinary approach to treating each individual cancer as a complex group of diseases, requiring consultation among medical and radiation oncologists, surgeons, diagnostic radiologists, pathologists and other board-certified experts specializing in cancer care. This multidisciplinary, team-driven approach results in improved patient care.

The Rush-Riverside Cancer Institute continues to grow and improve its quality of patient care through various cancer-related programs, available through the region, including prevention, early diagnosis, staging, optimal treatment, rehabilitation, lifelong follow-up for recurrent disease and, when needed, end of life care. When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments, genetic counseling and other patient-focused services including psycho-social support, patient navigation and survivorship care, all important elements that seek to improve cancer survivors' quality of life.

Learn more about Riverside's comprehensive approach to cancer care by visiting riversidehealthcare.org/cancer. To schedule an appointment with one of Riverside's cancer care experts, call the Rush-Riverside Cancer Institute at (815) 929-0010.

Boilerplate

Riverside Medical Center is located in Kankakee, Illinois, and is part of Riverside Healthcare, a fully-integrated healthcare system serving the needs of patients throughout five Illinois counties including Kankakee, Iroquois, Livingston, Will, Grundy and parts of Western Indiana. Riverside Medical Center is a 312-bed Level II Trauma hospital that provides a full scope of inpatient and outpatient care. Offering award-winning programs in heart care, cancer care, neurosurgery, orthopedics and a reputation for nursing excellence has placed Riverside as a leader nationally and locally. Riverside is the area's only Magnet® Recognized hospital and ranks among the top 5 percent of hospitals nationwide for clinical performance. The healthcare system has earned Truven Health's Top 100 Hospitals award eight times and is a multi-year recipient of Healthgrades Distinguished Hospital for Clinical Excellence Award. Riverside Medical Group includes more than 140 primary and specialty care providers that deliver care at sites throughout the region. Learn more about Riverside Healthcare at www.RiversideHealthcare.org.